Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
《生物技术日报》:CormediX、Mersana和葛兰素史克在《癌症协议》中遭遇监管挫折,BARDA有望为阿片类药物过量提供资金
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
Mersana Therapeutics Inc (NASDAQ:MRSN) announced a global collaboration that provides GSK plc (NYSE:GSK) an exclusive option to co-develop and commercialize XMT-2056.
Mersana will receive an upfront option purchase fee of $100 million. Mersana is also eligible to receive up to $1.36 billion in the form of an option exercise payment and development, regulatory and commercial milestone payments if GSK exercises its option.
Mersana has retained options to profit-share and to co...
Here's a roundup of top developments in the biotech space over the last 24 hours:
以下是过去 24 小时内生物技术领域的主要进展摘要:
Stocks In Focus
焦点股票
Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
Mersana、葛兰素史克签署了13.6亿美元的抗癌疗法Biobuck协议
Mersana Therapeutics Inc (NASDAQ:MRSN) announced a global collaboration that provides GSK plc (NYSE:GSK) an exclusive option to co-develop and commercialize XMT-2056.
Mersana Thareutics纳斯达克股票代码:MRSN)宣布了一项全球合作,该合作提供葛兰素史克公司(纽约证券交易所代码:GSK)是共同开发和商业化 XMT-2056 的独家选择。
Mersana will receive an upfront option purchase fee of $100 million. Mersana is also eligible to receive up to $1.36 billion in the form of an option exercise payment and development, regulatory and commercial milestone payments if GSK exercises its option.
Mersana将获得1亿美元的预付期权购买费。如果葛兰素史克行使期权,Mersana还有资格获得高达13.6亿美元的期权行使补助和开发、监管和商业里程碑补助金。
Mersana has retained options to profit-share and to co...
Mersana保留了...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
风险及免责提示
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
风险及免责提示
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!